Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Clinical Course of SARS-CoV-2 Infection in Adults with ESKD Receiving Outpatient Hemodialysis.Kidney360 · 2021
   Article
2. Challenge in diagnosis of COVID-19 in hemodialysis patient: a case report and brief review of the literature.CEN case reports · 2021
   Review
3. SARS-CoV-2 Antibodies in Hemodialysis Patients Six Months after Infection Compared to Healthcare Workers.International journal of nephrology · 2021
   Article
4. In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'American journal of kidney diseases : the official journal of the National Kidney Foundation · 2020
   Article
5. [SARS-CoV-2 screening in chronic hemodialysis patients in a third-level hospital and its peripheral centers:'one hour less in the Canary Islands'].Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia
   Article
6. SARS-CoV-2 screening in chronic hemodialysis patients in a third-level hospital and its peripheral centers: 'one hour less in the Canary Islands'.Nefrologia
   Article

Corrections and comments

• Commented on by
  In Reply to 'Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?'2020
• Comment on
  IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.2020

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as